TY - JOUR AU - Nair, S. AU - Dhodapkar, M. V. PY - 2017 DA - 2017// TI - Natural killer T cells in Cancer immunotherapy JO - Front Immunol VL - 8 UR - https://doi.org/10.3389/fimmu.2017.01178 DO - 10.3389/fimmu.2017.01178 ID - Nair2017 ER - TY - JOUR AU - Godfrey, D. I. AU - Kronenberg, M. PY - 2004 DA - 2004// TI - Going both ways: immune regulation via CD1d-dependent NKT cells JO - J Clin Invest VL - 114 UR - https://doi.org/10.1172/JCI200423594 DO - 10.1172/JCI200423594 ID - Godfrey2004 ER - TY - JOUR AU - Brutkiewicz, R. R. PY - 2006 DA - 2006// TI - CD1d ligands: the good, the bad, and the ugly JO - J Immunol VL - 177 UR - https://doi.org/10.4049/jimmunol.177.2.769 DO - 10.4049/jimmunol.177.2.769 ID - Brutkiewicz2006 ER - TY - JOUR AU - Wolf, B. J. AU - Choi, J. E. AU - Exley, M. A. PY - 2018 DA - 2018// TI - Novel approaches to exploiting invariant NKT cells in Cancer immunotherapy JO - Front Immunol VL - 9 UR - https://doi.org/10.3389/fimmu.2018.00384 DO - 10.3389/fimmu.2018.00384 ID - Wolf2018 ER - TY - JOUR AU - Pilones, K. A. AU - Aryankalayil, J. AU - Demaria, S. PY - 2012 DA - 2012// TI - Invariant NKT cells as novel targets for immunotherapy in solid tumors JO - Clin Dev Immunol VL - 2012 UR - https://doi.org/10.1155/2012/720803 DO - 10.1155/2012/720803 ID - Pilones2012 ER - TY - JOUR AU - Arrenberg, P. AU - Halder, R. AU - Dai, Y. AU - Maricic, I. AU - Kumar, V. PY - 2010 DA - 2010// TI - Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid JO - Proc Natl Acad Sci U S A VL - 107 UR - https://doi.org/10.1073/pnas.1000576107 DO - 10.1073/pnas.1000576107 ID - Arrenberg2010 ER - TY - JOUR AU - Dhodapkar, M. V. AU - Kumar, V. PY - 2017 DA - 2017// TI - Type II NKT cells and their emerging role in health and disease JO - J Immunol VL - 198 UR - https://doi.org/10.4049/jimmunol.1601399 DO - 10.4049/jimmunol.1601399 ID - Dhodapkar2017 ER - TY - JOUR AU - Crough, T. AU - Purdie, D. M. AU - Okai, M. AU - Maksoud, A. AU - Nieda, M. AU - Nicol, A. J. PY - 2004 DA - 2004// TI - Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies JO - Br J Cancer VL - 91 UR - https://doi.org/10.1038/sj.bjc.6602218 DO - 10.1038/sj.bjc.6602218 ID - Crough2004 ER - TY - JOUR AU - Giaccone, G. AU - Punt, C. J. AU - Ando, Y. AU - Ruijter, R. AU - Nishi, N. AU - Peters, M. PY - 2002 DA - 2002// TI - A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors JO - Clin Cancer Res VL - 8 ID - Giaccone2002 ER - TY - JOUR AU - Tachibana, T. AU - Onodera, H. AU - Tsuruyama, T. AU - Mori, A. AU - Nagayama, S. AU - Hiai, H. PY - 2005 DA - 2005// TI - Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-0877 DO - 10.1158/1078-0432.CCR-05-0877 ID - Tachibana2005 ER - TY - JOUR AU - Molling, J. W. AU - Langius, J. A. AU - Langendijk, J. A. AU - Leemans, C. R. AU - Bontkes, H. J. AU - Vliet, H. J. PY - 2007 DA - 2007// TI - Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.08.5787 DO - 10.1200/JCO.2006.08.5787 ID - Molling2007 ER - TY - JOUR AU - Tahir, S. M. AU - Cheng, O. AU - Shaulov, A. AU - Koezuka, Y. AU - Bubley, G. J. AU - Wilson, S. B. PY - 2001 DA - 2001// TI - Loss of IFN-gamma production by invariant NK T cells in advanced cancer JO - J Immunol VL - 167 UR - https://doi.org/10.4049/jimmunol.167.7.4046 DO - 10.4049/jimmunol.167.7.4046 ID - Tahir2001 ER - TY - JOUR AU - Bendelac, A. AU - Lantz, O. AU - Quimby, M. E. AU - Yewdell, J. W. AU - Bennink, J. R. AU - Brutkiewicz, R. R. PY - 1995 DA - 1995// TI - CD1 recognition by mouse NK1+ T lymphocytes JO - Science. VL - 268 UR - https://doi.org/10.1126/science.7538697 DO - 10.1126/science.7538697 ID - Bendelac1995 ER - TY - JOUR AU - Chennamadhavuni, D. AU - Saavedra-Avila, N. A. AU - Carreno, L. J. AU - Guberman-Pfeffer, M. J. AU - Arora, P. AU - Yongqing, T. PY - 2018 DA - 2018// TI - Dual modifications of alpha-Galactosylceramide synergize to promote activation of human invariant natural killer T cells and stimulate anti-tumor immunity JO - Cell Chem Biol VL - 25 UR - https://doi.org/10.1016/j.chembiol.2018.02.009 DO - 10.1016/j.chembiol.2018.02.009 ID - Chennamadhavuni2018 ER - TY - JOUR AU - Melo, A. s. h. a. n. t. y. M. AU - Zhang, L. e. i. AU - Dockry, É. i. l. i. s. F. AU - Petrasca, A. n. d. r. e. e. a. AU - Ghnewa, Y. a. s. m. e. e. n. G. AU - Breen, E. a. m. o. n. P. AU - Morrissey, M. a. r. i. a. E. AU - O’Reilly, C. i. a. r. a. AU - Bruen, R. o. b. y. n. AU - O’Meara, A. n. d. r. e. w. AU - Lysaght, J. o. a. n. n. e. AU - Zhu, X. i. a. n. g. m. i. n. g. AU - Doherty, D. e. r. e. k. G. PY - 2018 DA - 2018// TI - Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells JO - Glycobiology VL - 28 UR - https://doi.org/10.1093/glycob/cwy035 DO - 10.1093/glycob/cwy035 ID - Melo2018 ER - TY - JOUR AU - Kawano, T. AU - Cui, J. AU - Koezuka, Y. AU - Toura, I. AU - Kaneko, Y. AU - Sato, H. PY - 1998 DA - 1998// TI - Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells JO - Proc Natl Acad Sci U S A VL - 95 UR - https://doi.org/10.1073/pnas.95.10.5690 DO - 10.1073/pnas.95.10.5690 ID - Kawano1998 ER - TY - JOUR AU - Toura, I. AU - Kawano, T. AU - Akutsu, Y. AU - Nakayama, T. AU - Ochiai, T. AU - Taniguchi, M. PY - 1999 DA - 1999// TI - Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide JO - J Immunol VL - 163 ID - Toura1999 ER - TY - JOUR AU - Molling, J. W. AU - Moreno, M. AU - Groot, J. AU - Vliet, H. J. AU - Blomberg, B. M. AU - Eertwegh, A. J. PY - 2008 DA - 2008// TI - Chronically stimulated mouse invariant NKT cell lines have a preserved capacity to enhance protection against experimental tumor metastases JO - Immunol Lett VL - 118 UR - https://doi.org/10.1016/j.imlet.2008.02.007 DO - 10.1016/j.imlet.2008.02.007 ID - Molling2008 ER - TY - JOUR AU - Smyth, M. J. AU - Crowe, N. Y. AU - Pellicci, D. G. AU - Kyparissoudis, K. AU - Kelly, J. M. AU - Takeda, K. PY - 2002 DA - 2002// TI - Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide JO - Blood. VL - 99 UR - https://doi.org/10.1182/blood.V99.4.1259 DO - 10.1182/blood.V99.4.1259 ID - Smyth2002 ER - TY - JOUR AU - Crowe, N. Y. AU - Coquet, J. M. AU - Berzins, S. P. AU - Kyparissoudis, K. AU - Keating, R. AU - Pellicci, D. G. PY - 2005 DA - 2005// TI - Differential antitumor immunity mediated by NKT cell subsets in vivo JO - J Exp Med VL - 202 UR - https://doi.org/10.1084/jem.20050953 DO - 10.1084/jem.20050953 ID - Crowe2005 ER - TY - JOUR AU - Italiani, P. AU - Boraschi, D. PY - 2014 DA - 2014// TI - From monocytes to M1/M2 macrophages: phenotypical vs JO - Funct Differ Front Immunol VL - 5 ID - Italiani2014 ER - TY - JOUR AU - Bellora, F. AU - Castriconi, R. AU - Dondero, A. AU - Reggiardo, G. AU - Moretta, L. AU - Mantovani, A. PY - 2010 DA - 2010// TI - The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes JO - Proc Natl Acad Sci U S A VL - 107 UR - https://doi.org/10.1073/pnas.1007654108 DO - 10.1073/pnas.1007654108 ID - Bellora2010 ER - TY - JOUR AU - Moreno, M. AU - Molling, J. W. AU - Mensdorff-Pouilly, S. AU - Verheijen, R. H. AU - Hooijberg, E. AU - Kramer, D. PY - 2008 DA - 2008// TI - IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses JO - J Immunol VL - 181 UR - https://doi.org/10.4049/jimmunol.181.4.2446 DO - 10.4049/jimmunol.181.4.2446 ID - Moreno2008 ER - TY - JOUR AU - Ghinnagow, R. AU - Meester, J. AU - Cruz, L. J. AU - Aspord, C. AU - Corgnac, S. AU - Macho-Fernandez, E. PY - 2017 DA - 2017// TI - Co-delivery of the NKT agonist alpha-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses JO - Oncoimmunology. VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1339855 DO - 10.1080/2162402X.2017.1339855 ID - Ghinnagow2017 ER - TY - JOUR AU - Lee, Y. J. AU - Wang, H. AU - Starrett, G. J. AU - Phuong, V. AU - Jameson, S. C. AU - Hogquist, K. A. PY - 2015 DA - 2015// TI - Tissue-specific distribution of iNKT cells impacts their cytokine response JO - Immunity. VL - 43 UR - https://doi.org/10.1016/j.immuni.2015.06.025 DO - 10.1016/j.immuni.2015.06.025 ID - Lee2015 ER - TY - JOUR AU - Paul, S. AU - Kulkarni, N. AU - Shilpi AU - Lal, G. PY - 2016 DA - 2016// TI - Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2016.1235106 DO - 10.1080/2162402X.2016.1235106 ID - Paul2016 ER - TY - JOUR AU - Tian, G. AU - Courtney, A. N. AU - Jena, B. AU - Heczey, A. AU - Liu, D. AU - Marinova, E. PY - 2016 DA - 2016// TI - CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo JO - J Clin Invest VL - 126 UR - https://doi.org/10.1172/JCI83476 DO - 10.1172/JCI83476 ID - Tian2016 ER - TY - JOUR AU - Coquet, J. M. AU - Chakravarti, S. AU - Kyparissoudis, K. AU - McNab, F. W. AU - Pitt, L. A. AU - McKenzie, B. S. PY - 2008 DA - 2008// TI - Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0801631105 DO - 10.1073/pnas.0801631105 ID - Coquet2008 ER - TY - JOUR AU - Dashtsoodol, N. AU - Shigeura, T. AU - Tashiro, T. AU - Aihara, M. AU - Chikanishi, T. AU - Okada, H. PY - 2017 DA - 2017// TI - Natural killer T cell-targeted immunotherapy mediating long-term memory responses and strong antitumor activity JO - Front Immunol VL - 8 UR - https://doi.org/10.3389/fimmu.2017.01206 DO - 10.3389/fimmu.2017.01206 ID - Dashtsoodol2017 ER - TY - JOUR AU - Zhang, L. AU - Donda, A. PY - 2017 DA - 2017// TI - Alpha-Galactosylceramide/CD1d-antibody fusion proteins redirect invariant natural killer T cell immunity to solid tumors and promote prolonged therapeutic responses JO - Front Immunol VL - 8 UR - https://doi.org/10.3389/fimmu.2017.01417 DO - 10.3389/fimmu.2017.01417 ID - Zhang2017 ER - TY - JOUR AU - Watarai, H. AU - Sekine-Kondo, E. AU - Shigeura, T. AU - Motomura, Y. AU - Yasuda, T. AU - Satoh, R. PY - 2012 DA - 2012// TI - Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines JO - PLoS Biol VL - 10 UR - https://doi.org/10.1371/journal.pbio.1001255 DO - 10.1371/journal.pbio.1001255 ID - Watarai2012 ER - TY - JOUR AU - Gordy, L. E. AU - Bezbradica, J. S. AU - Flyak, A. I. AU - Spencer, C. T. AU - Dunkle, A. AU - Sun, J. PY - 2011 DA - 2011// TI - IL-15 regulates homeostasis and terminal maturation of NKT cells JO - J Immunol VL - 187 UR - https://doi.org/10.4049/jimmunol.1003965 DO - 10.4049/jimmunol.1003965 ID - Gordy2011 ER - TY - JOUR AU - Lin, H. AU - Nieda, M. AU - Nicol, A. J. PY - 2004 DA - 2004// TI - Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines JO - Eur J Immunol VL - 34 UR - https://doi.org/10.1002/eji.200324834 DO - 10.1002/eji.200324834 ID - Lin2004 ER - TY - JOUR AU - Leite-De-Moraes, M. C. AU - Hameg, A. AU - Arnould, A. AU - Machavoine, F. AU - Koezuka, Y. AU - Schneider, E. PY - 1999 DA - 1999// TI - A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement JO - J Immunol VL - 163 ID - Leite-De-Moraes1999 ER - TY - JOUR AU - Smyth, M. J. AU - Crowe, N. Y. AU - Godfrey, D. I. PY - 2001 DA - 2001// TI - NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma JO - Int Immunol VL - 13 UR - https://doi.org/10.1093/intimm/13.4.459 DO - 10.1093/intimm/13.4.459 ID - Smyth2001 ER - TY - JOUR AU - Smyth, M. J. AU - Wallace, M. E. AU - Nutt, S. L. AU - Yagita, H. AU - Godfrey, D. I. AU - Hayakawa, Y. PY - 2005 DA - 2005// TI - Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer JO - J Exp Med VL - 201 UR - https://doi.org/10.1084/jem.20042280 DO - 10.1084/jem.20042280 ID - Smyth2005 ER - TY - JOUR AU - Vliet, H. J. AU - Nishi, N. AU - Gruijl, T. D. AU - Blomberg, B. M. AU - Eertwegh, A. J. AU - Pinedo, H. M. PY - 2000 DA - 2000// TI - Human natural killer T cells acquire a memory-activated phenotype before birth JO - Blood. VL - 95 UR - https://doi.org/10.1182/blood.V95.7.2440 DO - 10.1182/blood.V95.7.2440 ID - Vliet2000 ER - TY - JOUR AU - Baev, D. V. AU - Peng, X. H. AU - Song, L. AU - Barnhart, J. R. AU - Crooks, G. M. AU - Weinberg, K. I. PY - 2004 DA - 2004// TI - Distinct homeostatic requirements of CD4+ and CD4- subsets of Valpha24-invariant natural killer T cells in humans JO - Blood. VL - 104 UR - https://doi.org/10.1182/blood-2004-04-1629 DO - 10.1182/blood-2004-04-1629 ID - Baev2004 ER - TY - JOUR AU - Eger, K. A. AU - Sundrud, M. S. AU - Motsinger, A. A. AU - Tseng, M. AU - Kaer, L. AU - Unutmaz, D. PY - 2006 DA - 2006// TI - Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions JO - PLoS One VL - 1 UR - https://doi.org/10.1371/journal.pone.0000050 DO - 10.1371/journal.pone.0000050 ID - Eger2006 ER - TY - JOUR AU - Paul, S. AU - Lal, G. PY - 2017 DA - 2017// TI - The molecular mechanism of natural killer cells function and its importance in Cancer immunotherapy JO - Front Immunol VL - 8 UR - https://doi.org/10.3389/fimmu.2017.01124 DO - 10.3389/fimmu.2017.01124 ID - Paul2017 ER - TY - JOUR AU - Senovilla, L. AU - Vacchelli, E. AU - Galon, J. AU - Adjemian, S. AU - Eggermont, A. AU - Fridman, W. H. PY - 2012 DA - 2012// TI - Trial watch: prognostic and predictive value of the immune infiltrate in cancer JO - Oncoimmunology. VL - 1 UR - https://doi.org/10.4161/onci.22009 DO - 10.4161/onci.22009 ID - Senovilla2012 ER - TY - JOUR AU - Coquet, J. M. AU - Kyparissoudis, K. AU - Pellicci, D. G. AU - Besra, G. AU - Berzins, S. P. AU - Smyth, M. J. PY - 2007 DA - 2007// TI - IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production JO - J Immunol VL - 178 UR - https://doi.org/10.4049/jimmunol.178.5.2827 DO - 10.4049/jimmunol.178.5.2827 ID - Coquet2007 ER - TY - JOUR AU - Michel, M. L. AU - Keller, A. C. AU - Paget, C. AU - Fujio, M. AU - Trottein, F. AU - Savage, P. B. PY - 2007 DA - 2007// TI - Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia JO - J Exp Med VL - 204 UR - https://doi.org/10.1084/jem.20061551 DO - 10.1084/jem.20061551 ID - Michel2007 ER - TY - JOUR AU - Oleinika, K. AU - Rosser, E. C. AU - Matei, D. E. AU - Nistala, K. AU - Bosma, A. AU - Drozdov, I. PY - 2018 DA - 2018// TI - CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells JO - Nat Commun VL - 9 UR - https://doi.org/10.1038/s41467-018-02911-y DO - 10.1038/s41467-018-02911-y ID - Oleinika2018 ER - TY - JOUR AU - Dhodapkar, M. V. AU - Geller, M. D. AU - Chang, D. H. AU - Shimizu, K. AU - Fujii, S. AU - Dhodapkar, K. M. PY - 2003 DA - 2003// TI - A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma JO - J Exp Med VL - 197 UR - https://doi.org/10.1084/jem.20021650 DO - 10.1084/jem.20021650 ID - Dhodapkar2003 ER - TY - JOUR AU - Molling, J. W. AU - Kolgen, W. AU - Vliet, H. J. AU - Boomsma, M. F. AU - Kruizenga, H. AU - Smorenburg, C. H. PY - 2005 DA - 2005// TI - Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load JO - Int J Cancer VL - 116 UR - https://doi.org/10.1002/ijc.20998 DO - 10.1002/ijc.20998 ID - Molling2005 ER - TY - JOUR AU - Gebremeskel, S. AU - Lobert, L. AU - Tanner, K. AU - Walker, B. AU - Oliphant, T. AU - Clarke, L. E. PY - 2017 DA - 2017// TI - Natural killer T-cell immunotherapy in combination with chemotherapy-induced immunogenic cell death targets metastatic breast Cancer JO - Cancer Immunol Res VL - 5 UR - https://doi.org/10.1158/2326-6066.CIR-17-0229 DO - 10.1158/2326-6066.CIR-17-0229 ID - Gebremeskel2017 ER - TY - JOUR AU - Bricard, G. AU - Cesson, V. AU - Devevre, E. AU - Bouzourene, H. AU - Barbey, C. AU - Rufer, N. PY - 2009 DA - 2009// TI - Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors JO - J Immunol VL - 182 UR - https://doi.org/10.4049/jimmunol.0711086 DO - 10.4049/jimmunol.0711086 ID - Bricard2009 ER - TY - JOUR AU - Motohashi, S. AU - Kobayashi, S. AU - Ito, T. AU - Magara, K. K. AU - Mikuni, O. AU - Kamada, N. PY - 2002 DA - 2002// TI - Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients JO - Int J Cancer VL - 102 UR - https://doi.org/10.1002/ijc.10678 DO - 10.1002/ijc.10678 ID - Motohashi2002 ER - TY - JOUR AU - Yang, Y. AU - Ueno, A. AU - Bao, M. AU - Wang, Z. AU - Im, J. S. AU - Porcelli, S. PY - 2003 DA - 2003// TI - Control of NKT cell differentiation by tissue-specific microenvironments JO - J Immunol VL - 171 UR - https://doi.org/10.4049/jimmunol.171.11.5913 DO - 10.4049/jimmunol.171.11.5913 ID - Yang2003 ER - TY - JOUR AU - Song, L. AU - Asgharzadeh, S. AU - Salo, J. AU - Engell, K. AU - Wu, H. W. AU - Sposto, R. PY - 2009 DA - 2009// TI - Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages JO - J Clin Invest VL - 119 UR - https://doi.org/10.1172/JCI37869 DO - 10.1172/JCI37869 ID - Song2009 ER - TY - JOUR AU - Liu, D. AU - Song, L. AU - Wei, J. AU - Courtney, A. N. AU - Gao, X. AU - Marinova, E. PY - 2012 DA - 2012// TI - IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity JO - J Clin Invest VL - 122 UR - https://doi.org/10.1172/JCI59535 DO - 10.1172/JCI59535 ID - Liu2012 ER - TY - JOUR AU - Gasser, O. AU - Sharples, K. J. AU - Barrow, C. AU - Williams, G. M. AU - Bauer, E. AU - Wood, C. E. PY - 2018 DA - 2018// TI - A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and alpha-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients JO - Cancer Immunol Immunother VL - 67 UR - https://doi.org/10.1007/s00262-017-2085-9 DO - 10.1007/s00262-017-2085-9 ID - Gasser2018 ER - TY - JOUR AU - Hayakawa, Y. AU - Rovero, S. AU - Forni, G. AU - Smyth, M. J. PY - 2003 DA - 2003// TI - Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.1630663100 DO - 10.1073/pnas.1630663100 ID - Hayakawa2003 ER - TY - JOUR AU - Ambrosino, E. AU - Terabe, M. AU - Halder, R. C. AU - Peng, J. AU - Takaku, S. AU - Miyake, S. PY - 2007 DA - 2007// TI - Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis JO - J Immunol VL - 179 UR - https://doi.org/10.4049/jimmunol.179.8.5126 DO - 10.4049/jimmunol.179.8.5126 ID - Ambrosino2007 ER - TY - JOUR AU - Shimizu, K. AU - Kurosawa, Y. AU - Taniguchi, M. AU - Steinman, R. M. AU - Fujii, S. PY - 2007 DA - 2007// TI - Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells JO - J Exp Med VL - 204 UR - https://doi.org/10.1084/jem.20070458 DO - 10.1084/jem.20070458 ID - Shimizu2007 ER - TY - JOUR AU - Parekh, V. V. AU - Lalani, S. AU - Kim, S. AU - Halder, R. AU - Azuma, M. AU - Yagita, H. PY - 2009 DA - 2009// TI - PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells JO - J Immunol VL - 182 UR - https://doi.org/10.4049/jimmunol.0803648 DO - 10.4049/jimmunol.0803648 ID - Parekh2009 ER - TY - JOUR AU - Kojo, S. AU - Elly, C. AU - Harada, Y. AU - Langdon, W. Y. AU - Kronenberg, M. AU - Liu, Y. C. PY - 2009 DA - 2009// TI - Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1 JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0904078106 DO - 10.1073/pnas.0904078106 ID - Kojo2009 ER - TY - JOUR AU - Parekh, V. V. AU - Wilson, M. T. AU - Olivares-Villagomez, D. AU - Singh, A. K. AU - Wu, L. AU - Wang, C. R. PY - 2005 DA - 2005// TI - Glycolipid antigen induces long-term natural killer T cell anergy in mice JO - J Clin Invest VL - 115 UR - https://doi.org/10.1172/JCI24762 DO - 10.1172/JCI24762 ID - Parekh2005 ER - TY - JOUR AU - Cortesi, F. AU - Delfanti, G. AU - Grilli, A. AU - Calcinotto, A. AU - Gorini, F. AU - Pucci, F. PY - 2018 DA - 2018// TI - Bimodal CD40/Fas-dependent crosstalk between iNKT cells and tumor-associated macrophages impairs prostate Cancer progression JO - Cell Rep VL - 22 UR - https://doi.org/10.1016/j.celrep.2018.02.058 DO - 10.1016/j.celrep.2018.02.058 ID - Cortesi2018 ER - TY - JOUR AU - Janakiram, N. B. AU - Mohammed, A. AU - Bryant, T. AU - Ritchie, R. AU - Stratton, N. AU - Jackson, L. PY - 2017 DA - 2017// TI - Loss of natural killer T cells promotes pancreatic cancer in LSL-Kras(G12D/+) mice JO - Immunology. VL - 152 UR - https://doi.org/10.1111/imm.12746 DO - 10.1111/imm.12746 ID - Janakiram2017 ER -